Understanding the Genetics of Asthma Request More Information Trial Objective By studying the genes involved with asthma, researchers hope to understand what causes the disease and how to better treat it. For this study, researchers are examining participants’ nasal cells and blood samples for patterns and signatures in their genetic codes. Researchers are collecting samples from participants with all types of asthma, but are particularly interested in gathering more information on Aspirin Exacerbated Respiratory Disease (AERD). AERD causes people to form nasal polyps and have an allergy to non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin. Enrollment New enrollment for this trial is temporarily paused Who Can Participate Adults between the age of 18-75 who have been diagnosed with asthma. Age: 18-75 Gender: Any Gender Estimated Time Commitment 1-2 office visits totaling up to 1.5 hours The main visit will last one hour for a nasal swab and blood draw. If asked to come for a follow up appointment, it would last approximately 30 minutes. × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Brian Modena, MD 303.398.1625 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors K23 Grant Principal Investigators Brian Modena, MD, MSc + × Brian Modena, MD, MSc Associate Professor Division of Allergy & Clinical Immunology Department of Medicine View Full Profile Make an Appoinment Request More Information Due to concerns around COVID-19 and our focus on helping to meet this momentous challenge, we have temporarily paused enrollment for this trial.